Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer casesGermline variants in <i>IL4</i>, <i>MGMT</i> and <i>AKT1</i> are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases, Published online: 03 January 2018; doi:10.1038/s41391-017-0029-2Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Source: Prostate Cancer and Prostatic Diseases - January 3, 2018 Category: Urology & Nephrology Authors: L. M. FitzGerald S. Zhao A. Leonardson M. S. Geybels S. Kolb D. W. Lin J. L. Wright R. Eeles Z. Kote-Jarai K. Govindasami G. G. Giles M. C. Southey J. Schleutker T. L. Tammela C. Sipeky K. L. Penney M. J. Stampfer H. Gronberg F. Wiklund P. Stattin J. Hugo Source Type: research